Visual Analogue ScaleNCT07015229
Septorhinoplasty and Pain Score Course
An observational study of Visual Analogue Scale, run by Istinye University.
Trial summary
To provide scientific contribution to more effective and timely pain management strategies in the postoperative period by evaluating the time-dependent course of pain scores and the effect of analgesic intervention timing on clinical outcomes in patients who underwent septorhinoplasty and who are followed in the… Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Visual Analogue Scale
- What is being tested?
- septorhinoplasty
- Type of treatment
- Surgery or procedure
- How many people
- 78 participants
- Where
- No sites listed yet
- Study dates
- 25 Jun 2025to 20 Jan 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients aged 18-65 years with ASA 1-3 who underwent elective septorhinoplasty
Who may be able to join
- Being 18 years of age or older,
- Being in ASA I-III class,
- Having undergone septorhinoplasty surgery under general anesthesia under elective conditions,
- Being monitored for at least 30 minutes in postoperative,
- Being conscious and able to assess pain with VAS.
Who cannot join
- Patients who have undergone surgical procedures other than septorhinoplasty (e.g. laparoscopic, gynecological, orthopedic, etc.)
- Inability to assess pain due to impaired consciousness, agitation, or sedation in the postoperative period
- History of opioid derivatives or continuous analgesic use in the preoperative period
- Cognitive impairment, psychiatric disease at a level that prevents communication, severe visual or hearing impairment
- History of neurological or neuromuscular disease
- Having undergone revision septorhinoplasty or other revision surgery
- Patients with VAS≥4 during their follow-up in the postoperative,
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: The Relationship of Pain Score Course and Analgesic Intervention Timing With Clinical Outcomes in the Postanesthetic Period After Septorhinoplasty
To provide scientific contribution to more effective and timely pain management strategies in the postoperative period by evaluating the time-dependent course of pain scores and the effect of analgesic intervention timing on clinical outcomes in patients who underwent septorhinoplasty and who are followed in the postanesthetic care unit.
- Conditions
- Visual Analogue Scale
- Being tested
- septorhinoplasty
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
septorhinoplastyProcedure or surgery
To provide scientific contribution to more effective and timely pain management strategies in the postoperative period by evaluating the time-dependent course of pain scores and the effect of analgesic intervention timing on clinical outcomes in patients who underwent septorhinoplasty and who are followed in the postanesthetic care unit.
What is being measured
The primary outcome is the main question the study is designed to answer.
visual analogue scale
0:no pain, 10:worst pain
Measured: 60 minutes
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Jun 2025
- Study start25 Jun 2025 (estimated)
- Primary completion4 Jan 2026 (estimated)
- Study completion20 Jan 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Visual Analogue ScaleStudies of the same condition, open and under way.
- More trials run by Istinye UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 78 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Istinye University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, İlke Dolgun, Haseki Training and Research Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07015229
- Sponsor's protocol ID
- haseki pacu cevahir
- Status last verified
- Jun 2025
- First submitted
- 3 Jun 2025
- Last updated
- 27 Jun 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Alshehri AA. Comparative Evaluation of Postoperative Pain Scores and Opioid Consumption in Septorhinoplasty After Administration of Single-Dose Preemptive Paracetamol and Ibuprofen: A Randomized Controlled Trial. Int Arch Otorhinolaryngol. 2023 Aug 4;27(3):e471-e477. doi: 10.1055/s-0042-1749386. eCollection 2023 Jul.
PubMed 37564463Perianez CAH, Castillo-Diaz MA, Barbosa MH, De Mattia AL. Pain Predictors in Patients in the Postanesthesia Care Unit. J Perianesth Nurs. 2024 Aug;39(4):652-658. doi: 10.1016/j.jopan.2023.11.010. Epub 2024 Feb 3.
PubMed 38310508
Study at a glance
From the registry record, last updated by the sponsor on 27 Jun 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Relationship of Pain Score Course and Analgesic Intervention Timing With Clinical Outcomes in the Postanesthetic Period After Septorhinoplasty
- ClinicalTrials.gov ID
- NCT07015229
- Acronym / sponsor ID
- haseki pacu cevahir
- Conditions
- Visual Analogue Scale
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 78 participants (estimated)
- Lead sponsor
- Istinye UniversityUniversity, hospital or other
- Study start
- 25 Jun 2025 (estimated)
- Primary completion
- 4 Jan 2026 (estimated)
- Study completion
- 20 Jan 2026 (estimated)
- First posted
- 11 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To provide scientific contribution to more effective and timely pain management strategies in the postoperative period by evaluating the time-dependent course of pain scores and the effect of analgesic intervention timing on clinical outcomes in patients who underwent septorhinoplasty and who are followed in the postanesthetic care unit.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients aged 18-65 years with ASA 1-3 who underwent elective septorhinoplasty
Key inclusion criteria (5 listed)
- Being 18 years of age or older,
- Being in ASA I-III class,
- Having undergone septorhinoplasty surgery under general anesthesia under elective conditions,
- Being monitored for at least 30 minutes in postoperative,
- Being conscious and able to assess pain with VAS.
Key exclusion criteria (7 listed)
- Patients who have undergone surgical procedures other than septorhinoplasty (e.g. laparoscopic, gynecological, orthopedic, etc.)
- Inability to assess pain due to impaired consciousness, agitation, or sedation in the postoperative period
- History of opioid derivatives or continuous analgesic use in the preoperative period
- Cognitive impairment, psychiatric disease at a level that prevents communication, severe visual or hearing impairment
- History of neurological or neuromuscular disease
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| septorhinoplastyTo provide scientific contribution to more effective and timely pain management strategies in the postoperative period by evaluating the time-dependent course of pain scores and the effect of analgesic intervention timing on clinical outcomes in patients who underwent septorhinoplasty and who are followed in the postanesthetic care unit. | Procedure or surgery | – |
Primary outcome
visual analogue scale
Time frame: 60 minutes
0:no pain, 10:worst pain
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Jun 2025.
- Results publication: PubMed 37564463Alshehri AA. Comparative Evaluation of Postoperative Pain Scores and Opioid Consumption in Septorhinoplasty After Administration of Single-Dose Preemptive Paracetamol and Ibuprofen: A Randomized Controlled Trial. Int Arch Otorhinolaryngol. 2023 Aug 4;27(3):e471-e477. doi: 10.1055/s-0042-1749386. eCollection 2023 Jul.
- Results publication: PubMed 38310508Perianez CAH, Castillo-Diaz MA, Barbosa MH, De Mattia AL. Pain Predictors in Patients in the Postanesthesia Care Unit. J Perianesth Nurs. 2024 Aug;39(4):652-658. doi: 10.1016/j.jopan.2023.11.010. Epub 2024 Feb 3.
- Individual participant dataSharing planned: No
Related trials for Visual Analogue Scale
Recruiting
WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department
Acute Hypoxic Respiratory Failure, Acute Respiratory Distress Syndrome (ARDS)
Recruiting
Neural and Psychological Mechanisms of Pain Perception
Pain, Normal Physiology
RecruitingObservational study
Stroke Hemiplegic Shoulder Pain: Ultrasound Findings and VAS (Cross-Sectional)
Hemiplegic Shoulder Pain, Stroke
Not yet recruiting
Effect of the CALAJECT System on Pain Perception, Heart Rate, and Blood Pressure During Inferior Alveolar Nerve Block: A Randomized Controlled Clinical Trial
Local Anesthesia in Dentistry
Not yet recruiting
Pudendal Nerve Block for Pain Relief During Episiotomy Repair
Episiotomy , Perineal Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Questions about this trial
What is this clinical trial studying?
An observational study of Visual Analogue Scale, run by Istinye University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 27 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact ilke dolgun (+905555485632, ilkeser2004@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
visual analogue scale (time frame: 60 minutes). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07015229, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jun 2025.